Release 5 Preview #3

This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Immunization-example-protocol

Public Health and Emergency Response Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile Immunization.

Generated Narrative

id: protocol

identifier: id: urn:oid:1.3.6.1.4.1.21367.2005.3.7.1234

status: completed

vaccineCode: Twinrix (HepA/HepB)

manufacturer: Generated Summary: id: hl7; name: Health Level Seven International; alias: HL7 International; ph: (+1) 734-677-7777, fax: (+1) 734-677-6622, hq@HL7.org

lotNumber: PT123F

expirationDate: 2018-12-15

patient: Generated Summary: id: example; Medical record number: 12345 (USUAL); active; Peter James Chalmers (OFFICIAL), Jim , Peter James Windsor (MAIDEN); -unknown-(HOME), ph: (03) 5555 6473(WORK), ph: (03) 3410 5613(MOBILE), ph: (03) 5555 8834(OLD); gender: male; birthDate: 1974-12-25;

encounter: Generated Summary: id: example; status: in-progress; inpatient encounter

occurrence: 2018-06-18

primarySource: true

location: Generated Summary: id: 1; id: B1-S.F2; status: active; name: South Wing, second floor; alias: BU MC, SW, F2, alias: Burgers University Medical Center, South Wing, second floor; description: Second floor of the Old South Wing, formerly in use by Psychiatry; mode: instance; ph: 2328(WORK), fax: 2329(WORK), second wing admissions, http://sampleorg.com/southwing(WORK); Wing

site: left arm

route: Injection, intramuscular

doseQuantity: 5 mg

performer
function: Ordering Provider
actor: Generated Summary: id: example; id: 23; active; Adam Careful

performer
function: Administering Provider
actor: Generated Summary: id: example; id: 23; active; Adam Careful

isSubpotent: false

programEligibility: Not Eligible

fundingSource: Private

protocolApplied
series: 2-dose
targetDisease: Viral hepatitis, type A
doseNumber: 1

protocolApplied
series: 3-dose
targetDisease: Type B viral hepatitis
doseNumber: 2
seriesDoses: 3

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.